Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-01-22

FDA Approved: RANOLAZINE — Supplemental Application (Viona Pharmaceuticals Inc)

View source ↗

Summary

FDA approved a supplemental application for ranolazine filed by Viona Pharmaceuticals Inc (ANDA 210188). This action completes an additional approval step for t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ranolazine (ranolazine)

Snippet

SUPPL AP for RANOLAZINE (RANOLAZINE)